IP Library Granted Patent US 7,148,254
Granted Patent B2
US 7,148,254 · App. 10/972,546 · Granted Dec 12, 2006

2-Phenylbenzofuran derivatives, a process for preparing them, and their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,254
App. No.
10/972,546
Granted
Dec 12, 2006
Kind
B2
Abstract

The present invention relates to 2-phenylbenzofurans of formula (I) which are formed, during fermentation, by the microorganism Aspergillus flavipes ST003878 (DSM 15290), to a process for preparing them and to their use as pharmaceuticals for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses.

Claims (14)

1. A compound of formula (I)

wherein

R 1 and R 2 are, independently of each other, H, OH or —O—(C 1 –C 6 )-alkyl, and

R 3 , R 4 , R 5 , R 6 and R 7 are, independently of each other, H, —(C 1 –C 6 )-alkyl or —C(O)—(C 1 –C 6 )-alkyl,

or a physiologically tolerated salt of a compound of formula (I).

2. A compound of formula (I) as claimed in claim 1 , wherein both R 1 and R 2 are H.

3. A compound of formula (I) as claimed in claim 1 , wherein R 3 , R 4 , R 5 , R 6 and R 7 are, independently of each other, H or methyl.

4. A compound of formula (I) as claimed in claim 1 , which is the compound of formula (II):

5. A compound of formula (I) as claimed in claim 1 , which has the formula (III):

6. A compound of formula (I) as claimed in claim 1 , which is the compound of formula (IV):

7. A compound of formula (I) as claimed in claim 1 , which is characterized by formula (V):

8. A pharmaceutical composition comprising a compound of formula (I) as claimed in claim 1 , or of a physiologically tolerated salt thereof.

9. The pharmaceutical composition of claim 8 for the treatment and/or prophylaxis of bacterial infectious diseases and/or mycoses.

10. A process for producing a pharmaceutical as claimed in claim 9 , which comprises mixing at least one compound of formula (I) with one or more pharmacologically suitable auxiliary substances or carrier substances.

Assignments (2)
CHANGE OF NAME Recorded Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2005
From: VERTESY, LASZLO; KURZ, MICHAEL; MARKUS-ERB, ASTRID; TOTI, LUIGI
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 015825/0329 →